Introduction T ype II diabetes mellitus (DM) increases a person's risk of having myocardial and cerebral infarctions in highly industrialized countries.
(1) This disease has genetic and environmental causes, with diet being an important environmental factor. A highcarbohydrate diet increases postprandial levels of blood glucose and insulin, and long-term consumption of diets high in carbohydrates leads to insulin resistance. (2) Insulin resistance increases risk for DM and coronary artery disease. (3, 4) The recommend beneficial controlling blood glucose concentration is that supplies suitable energy intake and well-balanced daily diet. Food digestibility directly affects blood glucose and insulin levels. (8) White rice is an important staple carbohydrate food, but its glycemic index (GI) makes it inappropriate for frequent consumption by patients with diabetes. (9) A new type of rice, pregerminated brown rice (PGBR), has become available in Japan and Taiwan. PGBR, which created by soaking brown rice kernels in water to slightly germinate, is considered more healthful than white rice because it is richer in dietary fiber. (10) PGBR comprised endosperm, aleurone layer, bran layer and germ were considered to have physical shape that delayed digestion and absorption of carbohydrate. (11) Moreover, PGBR contained various functional compounds such as γ-aminobutyric acid (GABA) and γ-oryzanol, which improved levels of blood glucose, lipids and peroxidation. (10) (11) (12) (13) Many reports had been proved that PGBR could ameliorate DM or hyperlipidemia, (10) (11) (12) (13) (14) (15) (16) however, not much research presented the biochemical mechanisms of PGBR in improving DM or hyperlipidemia. The aim of this study is to investigate the effect and action mechanism of long-term consumption of PGBR in the prevention of high fat diet (HFD)-induced hyperglycemia. We examined the mechanism on the secretion of insulin and the protein levels of insulin receptor, glucose transporters, and the enzymes involved in the metabolism of glucose.
Experimental Methods
Animals. Mice (C57BL/6J strain) were obtained by the National Laboratory Animal Breeding and Research Center (Taipei, Taiwan) and housed under constant temperature and illumination (light between 7:30 and 19:30). Water and standard regular diet (SRD, purchased from National Laboratory Animal Breeding and Research Center, the crude fat and crude protein in SRD are soybean oil and soybean protein) were made available ad libitum. After an acclimatization period, the six-week-old mice were randomly divided into three groups. Group 1 (n = 8) was fed the SRD and group 2 (n = 8) was fed high-fat diet (HFD) for 16 weeks. The HFD was made from SRD with the addition of lard oil and cholesterol for increasing the calories and metabolic syndrome. And the whey protein was added in HFD enhancing the protein levels for the cause of similar with SRD. HFD contained 60% energy from fat, 21.4% energy from carbohydrates and 18.7% energy from protein. In group 3 (n = 8), we replaced the source of carbohydrates in HFD, which was, with PGBR (Asia RICE Biotech, Inc, Taipei, Taiwan) and fed it to the mice for 16 weeks. The levels of dietary fibers of all diets had no significant different. The nutrient compositions of diets we used in this experiment are shown in Table 1 . For all groups, body weight was measured weekly, and oral glucose tolerance test (OGTT) was T recorded every four weeks. At the end of the study, we collected blood for biochemical assay and excised the liver and skeletal muscle from all mice and stored these tissues in protein-lysis buffer solution at −80°C until analysis. This study was approved by the Animal Care and Use Committee of Meiho University.
Measurement of blood pressure and heart rate. For all groups, blood pressure and heart rate were monitored by mice tail cuff blood pressure system: Softron BP 98-A (Softron Co., LTD, Tokyo, Japan).
Measurement of OGTT. The mice of all groups were given glucose (2 g/kg) after fasting 12 h in the last week. Blood samples were collected prior to glucose administration (0 min) and then at 30, 60 and 120 min after glucose loading. Blood glucose was measured using a glucose test strip (Glucotide, Bayer, Indianapolis, Indiana). The incremental area under the curve (IAUC) for glucose concentration was calculated according to the method described by Wolever and Jenkins. (17) Measurement of serum biochemical parameters. Blood samples were collected to measure glucose, glycated hemoglobin (HbA1c) which was performed using a HITACHI Clinical Analyzer 7070 and insulin levels, which were performed using an ELISA kit (Mercodia, Uppsala, Sweden).
Western blot analysis of skeletal muscle tissue. Following previously described procedures, (18) the homogenized tissues were centrifuged at 12,500 × g for 30 min and the supernatants were stored at -70°C until further analysis. Aliquots of tissue homogenates were used for protein assay (Bio-Rad protein assay reagent (Bio-Rad Laboratories Taiwan Ltd, Taipei, Taiwan) and Western blot analysis. The skeletal muscle homogenates were probed for insulin receptor (IR), insulin receptor substrate-1 (IRS-1), phosphatidylinositol-3-kinase (PI3K), Akt, glucose transporter-1 (GLUT-1), GLUT-4, AMP-activated protein kinase (AMPK), glucogen synthase kinase (GSK), glucose 6-phosphatase (G6Pase), glucokinase (GCK), peroxisome proliferator-activated receptor γ (PPARγ) and phosphoenolpyruvate carboxykinase (PEPCK) antibodies (Santa Cruz Biotechnology, Paso Robles, CA; 1:500 dilution) and IgG conjugated antibody (Santa Cruz Biotechnology; 1:10000 dilution). The relative expression of those proteins in each tissue was quantified by densitometric scanning of the western blots using Image-pro plus software (Media Cybernetics, Rockville, MD).
Western blot analysis of liver tissue. The homogenized liver tissues were analyzed by IR, IRS-1, PI3K, Akt, AMPK, GSK, G6Pase, GCK, PPARγ and PEPCK antibodies (Santa Cruz Biotechnology, Santa Cruz; 1:500 dilution) and IgG conjugated antibody (Santa Cruz Biotechnology, Santa Cruz; 1:10000 dilution). The relative expression of those proteins in each tissue was quantified by densitometric scanning of the western blots using Image-pro plus software (Media Cybernetics, MD) as previously described. (18) Statistical analysis of data. Results are expressed as mean ± SE. Statistical differences were determined by independent and paired Student's t test in unpaired samples. If a significant difference was found, Tukey's or Scheffe's test was used for further analysis. A p value <0.05 was considered significant in all experiments. Analysis of data and plotting of figures was performed using SigmaStat: ver. 2.03 and SigmaPlot: ver. 8.0 (Systat Software, Point Richmond, CA).
Results
Effect of PGBR in body weight and weight gain. After 16 weeks, SRD group weight gained approximately 50.4%, and HFD group weight gained approximately 116.8%. The HFD group gained significantly more weight in total than the SRD group. In the HFD + PGBR group, weight was gained but more gradually (68.2%). Compared with the HFD group, weight gain was inhibited in the HFD + PGBR group (Table 2 ). Comparing the food intake per day, all groups had no significant difference in SRD group: 22.6 ± 8.4 g, in HFD group: 25.6 ± 7.6 g and in HFD + PGBR group: 26.2 ± 7.8 g, respectively.
Effect of PGBR in blood pressure and heart rate. The systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean blood pressure (MBP) of HFD group were higher significantly in mice eating the HFD, compared those fed the standard regular diet. In the HFD + PGBR group, the SBP, DBP and MBP were similar with SRD group (Table 3) .
Effect of PGBR in OGTT. After glucose administration (oral, 2 g/kg) 0, 30, 60 and 120 min, the HFD group had a higher blood glucose levels than the SRD group. In the HFD + PGBR group, the blood glucose was recovered, suggesting that PGBR exerted a significant hypoglycemic effect in hyperglycemic mice (Table 4) .
Effect of PGBR in biochemical parameters. The HFD group had a 2.3-fold higher blood glucose level and 1.1-fold higher HbA1c level than the SRD group, though no obvious change in insulin levels was found. In the HFD + PGBR group, blood glucose and HbA1c levels were found to be obviously ameliorated. PGBR significantly increased the insulin levels.
The proteins expressions of glucose metabolism in skeletal muscle. Western blot analysis of the skeletal muscle isolated from HFD group revealed lower levels of IR (2.6-fold), IRS-1 (2.7-fold), PI3K (1.3-fold), GLUT-4 (1.2-fold) and GCK (1.7-fold) proteins, and a higher level of GSK (1.8-fold) protein, compared with the SRD group. PGBR was found to improve the expressions of those proteins. In the HFD + PGBR group, there were significant increases in IR (2.4-fold), IRS-1 (2.4-fold), PI3K 28.9 ± 3.8* (1.2-fold), Akt (1.4-fold), GLUT-1 (1.7-fold), GLUT-4 (1.3-fold) ( Fig. 1) , GCK (2.4-fold) and PPARγ (1.4-fold) protein levels. GSK (1.4-fold) protein level was recovered in skeletal muscle (Fig. 2 ). There were not obvious changes in the protein expressions of AMPK, G6Pase and PEPCK in any of the groups (data not shown).
The protein expressions of glucose metabolic enzymes in liver. Fig. 3 and 4 show the expressions of IR, IRS-1, PI3K, Akt, AMPK, GCK, GSK and PPARγ proteins in the mice. Compared with SRD group, the protein expressions of the following were decreased in the HFD group: IR (10%), Akt (13%), AMPK (11%), GCK (10%) and PPARγ (10%), though expression of GSK showed no significant change. In the HFD + PGBR group, PGBR significantly increased the protein expressions of IR (30%), IRS-1 (33%), PI3K (20%), Akt (14%), AMPK (15%) (Fig. 3) , GCK (7%) and PPARγ (24%), and decreased GSK (27%) (Fig. 4 ). There were no obvious changes in the protein expressions of G6Pase and PEPCK in all groups (data not shown).
Discussion
In developed countries, the cure and prevention of type II diabetes mellitus (T2DM) have become important concerns. The development of T2DM has been related with diets high in fat and sugar. Therefore, good dietary habits are helpful for decreasing the pathogenesis and mortality of T2DM. (14) PGBR, which is a new type of rice comprised of endosperm, aleurone layer, bran layer and germ, is thought to have physical shape that delays digestion and absorption of carbohydrate.
(11) The present shows that consuming PGBR as a staple carbohydrate markedly decreased fasting blood glucose and HbA1c and enhanced insulin levels in hyperglycemic mice.
Based on the findings of our OGTT, which reflects current blood glucose status and insulin reaction, PGBR can improve HFD-induced glucose tolerance. Therefore, the use of PGBR as a main source of carbohydrate can efficaciously ameliorate hyperglycemia. Table 1 compares the nutrient compositions of the diets used in this experiment. The SRD had a lower proportion of calories, crude fat, and cholesterol and higher proportion of carbohydrate. HFD and HFD + PGBR had the similar ratio of calories, carbohydrate, crude fat, protein and cholesterol. Only HFD + PGBR had γ-aminobutyric acid (GABA) and γ-oryzanol. Although, the dietary fiber of SRD and HFD + PGBR was slightly higher than that of HFD, we do not believe that this slight increase in higher dietary fiber had an obvious effect in the regulation of weight, blood glucose and blood pressure. GABA and γ-oryzanol which are markedly enhanced in PGBR, (10, 13, 15) regulates blood pressure, affects nervous system as neurotransmitter, and potentiates insulin secretion from the pancreases. (16, 19, 20) The current study also found GABA and γ-oryzanol to be higher in PGBR (Table 1) . The mice that ate HFD + PGBR in our study had less weight gain and lower blood glucose and blood pressure (Table 2-5), suggesting that the GABA and γ-oryzanol of PGBR can help regulate HFD-induced disorders. To examine the hypoglycemic effects of PGBR extracts will be our next challenges. A significant metabolic abnormality in DM is the diminished ability of insulin-sensitive tissues to take up and metabolize glucose.
(21) Skeletal muscle is the primary site of insulinstimulated glucose disposal and has been suggested to be the major tissue responsible for postprandial hyperglycemia in insulin-resistant subjects. (22) It is likely that the impaired insulin action associated with DM alters the expression or function of proteins which are components of the insulin receptor (IR) signing pathway and the glucose transport system. (23, 24) Insulin action is limited through hormone binding to cell surface insulin receptor, which triggers a cascade of intracellular phosphorylation. Insulin binding to the extracellular subunit stimulates the tyrosine kinase, and the kinase induces the phosphorylation of nonreceptor proteins, including insulin receptor substrate (IRS). IRS stimulates phosphatidyl-inositol 3-kinase (PI 3-kinase), and serine/threonine kinase PI3K-linked protein kinase B (Akt/PKB) activity, (25) (26) (27) and then activates the glucose transporter (GLUT) to uptake glucose into cell.
(28) GLUT-1 is the basal glucose transporter isoform for glucose transporter, and GLUT-4, an insulin-sensitive isoform, is only expressed in insulin-responsive cells. (29) (30) (31) Although the insulin levels of HFD group had no significant different with SRD group, the protein expressions of IR, IRS-1, PI3K, Akt and GLUT-4 were reduced by hyperglycemia in the HFD group. We suggested that the course of insulin resistance in this animal model was not induced yet. However, PGBR significantly increased insulin levels, and the expressions of IR, IRS-1, PI3K, Akt, GLUT-1 and GLUT-4 in the group whose HFD had been modified by the replacement with of the original carbohydrate with PGBR ( Fig. 1 and 3 ). Based on our results, PGBR was able to ameliorate hyperglycemia-induced insulin related proteins reducing and increase the glucose uptake into the cells thereby regulating blood glucose levels.
T2DM is a metabolic disease characterized by chronic hyperglycemia caused by abnormal glucose use in skeletal muscle (32) or increased hepatic glucose production. (33, 34) AMP-activated protein kinase (AMPK), glucokinase (GCK), peroxisome proliferatoractivated receptor γ (PPARγ) and glycogen synthase kinase (GSK) are related to the metabolism of glucose. AMPK is reduced in the skeletal muscle of obese and type 2 diabetic humans and rodents, and it may be a potential target for the treatment of obesity induced insulin resistance. Pharmacological activation of AMPK promotes glucose uptake and insulin sensitivity. (35) Glucokinase (GCK) is an enzyme that facilitates phosphorylation of glucose to glucose-6-phosphate, an important preparer of glucose for glycolysis and glycogen synthesis. (36) Peroxisome proliferator-activated receptor γ (PPARγ) has been identified as a key regulator of adipocyte differentiation and lipid metabolism, and its role in regulating glucose homeostasis has been established. (37) An increase in the expression of PPAR-γ increases the ability of insulin to mediate tissue glucose uptake and maintain glucose homeostasis. (38) Glycogen synthase kinase (GSK) is initially characterized as a critical enzyme involved in glycogen biosynthesis. Enhanced GSK activation decreases glycogen production, and its inhibitors have also shown promise in the treatment of T2DM. (39, 40) In our results, HFD-induced hyperglycemia reduced the protein expressions of AMPK, GCK and PPARγ and increased GSK. PGBR ameliorated the protein expressions of AMPK, GCK, PPARγ and GSK (Fig. 2, 3 and 4) . We suggest that PGBR improved HFDinduced hyperglycemia by increasing AMPK and PPARγ expres- sions to enhance insulin-mediated glucose uptake and glucose homeostasis. At the same time, PGBR increased GCK and inhibited GSK to enhance glycolysis and glycogen synthesis.
In conclusion, PGBR lowers blood glucose and blood pressure and improves glucose tolerance in mice with HFD-induced hyperglycemia. Moreover, PGBR recovered the protein expressions of IR, IRS-1, PI3K, Akt, GLUT-1, GLUT-4, AMPK, GCK, PPARγ and GSK. Based on our results, PGBR ameliorated hyperglycemia by increasing insulin secretion, insulin receptor levels, enhancing glucose to transport into cell and glucose metabolism. PGBR was able to increase insulin secretion, insulin receptor expression, glucose uptake, and glycolysis, glycogenesis (Fig. 5) . Taken together, these findings suggest that PGBR might be used to help control HFD-induced metabolic syndrome, especially in those who often use rice as a staple food. . Hypothetical mechanisms of PGBR in HFD induced hyperglycemia. The action mechanisms of PGBR ameliorating hyperglycemia occurred through increases in insulin secretion, insulin receptor levels and enhancement of glucose to transport into cell and glucose metabolisms. The protein levels of IR, IRS 1, PI3K, Akt, GLUT 1, GLUT 4, AMPK, GCK, PPARγ and GSK in skeletal muscle and liver were recovered by PGBR. Taken together, PGBR was able to increase insulin secretion, insulin receptor sensitivity, glucose uptake, and glycolysis, glycogenesis.
